New Antibody Shows Promise in Lupus

(MedPage Today) -- Initial clinical studies of epratuzumab in patients with active, moderate-to-severe systemic lupus erythematosus are suggesting promise for this monoclonal antibody.

Source: MedPage Today Primary Care - March 12, 2014 Category: Primary Care Source Type: news